Stablix, Inc.
Biotechnology
450 East 29th Street
24 employees
- Employees
- 24
- Contacts
- 3
- Emails
- 3
- Phones
- 1
Stablix, Inc. Overview
- Headquarters
- 450 East 29th Street
- Website
- www.stablix.com
- Industry
- Biotechnology
- Employees
- 24
- Funding
- 63.0M
Keywords
About Stablix, Inc.
Stablix is pioneering an entirely new field of targeted deubiquitination therapeutics (TDT) to bring transformative medicines to patients with unmet medical need. Co-located in New York City and Boston, we are a creative and multidisciplinary team of scientists, innovators and leaders dedicated to changing the way we approach drug development by establishing a powerful small-molecule modality for a wide variety of devastating diseases.
Stablix, Inc. Contact Details
- People in AeroLeads
- 4
- With contact data
- 3
- Email contacts
- 3
- 75.0% coverage
- Phone contacts
- 1
- 25.0% coverage
Stablix, Inc. Org Chart
Sample employees and titles| Name | Title | Location | Contact |
|---|---|---|---|
| Stephen P. Hale | Founder and CEO at Dg Medicines |
View
|
|
| Tony Kingsley | Biotech Executive | Greater Boston, United States |
Email
Phone
|
| Eddine Saiah | Chief Scientific Officer at Stablix | Greater Boston, United States |
Email
|
| Andrew Turnbull | Group Leader, Structural Biology | United Kingdom |
Email
|
Employees by Management Level
Executive
2 profiles
Individual contributor
2 profiles
Compare Similar Companies to Stablix, Inc.
Kymera Therapeutics
Biotechnology Research
Relay Therapeutics
Biotechnology Research
Curie.Bio
Biotechnology Research
Stabilix Corporation
Information Technology & Services
CAMP4 Therapeutics
Biotechnology Research
Entact Bio
Biotechnology Research
BIOTECH XYZ
Non-Profit Organization Management
Nested Therapeutics
Biotechnology Research
Sharper Sense
Medical Equipment Manufacturing
Vicinitas Therapeutics
Biotechnology Research